# A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

> **NCT05768269** · — · RECRUITING · sponsor: **Century Therapeutics, Inc.** · enrollment: 375 (estimated)

## Conditions studied

- Hematological Malignancy
- Solid Tumor Malignancy

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05768269
- **Lead sponsor:** Century Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-29
- **Primary completion:** 2040-03
- **Final completion:** 2040-03
- **Target enrollment:** 375 (ESTIMATED)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05768269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05768269, "A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05768269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*